UG vs. SHOT, PMN, ICCC, NAII, APLM, PXDT, XLO, ESLA, CTCX, and ECOR
Should you be buying United-Guardian stock or one of its competitors? The main competitors of United-Guardian include Safety Shot (SHOT), ProMIS Neurosciences (PMN), ImmuCell (ICCC), Natural Alternatives International (NAII), Apollomics (APLM), Pixie Dust Technologies (PXDT), Xilio Therapeutics (XLO), Estrella Immunopharma (ESLA), Carmell (CTCX), and electroCore (ECOR). These companies are all part of the "medical" sector.
United-Guardian (NASDAQ:UG) and Safety Shot (NASDAQ:SHOT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk, community ranking and profitability.
In the previous week, Safety Shot had 6 more articles in the media than United-Guardian. MarketBeat recorded 19 mentions for Safety Shot and 13 mentions for United-Guardian. Safety Shot's average media sentiment score of -0.12 beat United-Guardian's score of -0.32 indicating that Safety Shot is being referred to more favorably in the news media.
United-Guardian has higher revenue and earnings than Safety Shot. Safety Shot is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.
United-Guardian has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Safety Shot has a beta of 1.9, suggesting that its stock price is 90% more volatile than the S&P 500.
United-Guardian has a net margin of 23.71% compared to Safety Shot's net margin of -367.77%. United-Guardian's return on equity of 24.26% beat Safety Shot's return on equity.
23.2% of United-Guardian shares are held by institutional investors. Comparatively, 12.6% of Safety Shot shares are held by institutional investors. 29.0% of United-Guardian shares are held by insiders. Comparatively, 23.1% of Safety Shot shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
United-Guardian received 178 more outperform votes than Safety Shot when rated by MarketBeat users.
Summary
United-Guardian beats Safety Shot on 10 of the 14 factors compared between the two stocks.
Get United-Guardian News Delivered to You Automatically
Sign up to receive the latest news and ratings for UG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
United-Guardian Competitors List
Related Companies and Tools
